Esther Titos Selected Research

Autacoids

7/2022	Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease.
1/2019	Leukocytes from obese individuals exhibit an impaired SPM signature.
8/2016	Pro-resolving mediators produced from EPA and DHA: Overview of the pathways involved and their mechanisms in metabolic syndrome and related liver diseases.
1/2016	Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
12/2013	Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation.
1/2012	Resolution of inflammation in obesity-induced liver disease.
6/2009	Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther Titos Research Topics

Disease

27	Inflammation (Inflammations) 10/2020 - 09/2003
14	Insulin Resistance 11/2017 - 12/2008
13	Fibrosis (Cirrhosis) 01/2021 - 02/2002
13	Obesity 01/2019 - 12/2008
6	Fatty Liver 07/2022 - 12/2008
5	Liver Diseases (Liver Disease) 11/2018 - 01/2003
5	Non-alcoholic Fatty Liver Disease 01/2012 - 12/2010
2	Alcoholic Fatty Liver 01/2018 - 02/2014
2	Hypoxia (Hypoxemia) 12/2017 - 02/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 07/2011
2	Metabolic Diseases (Metabolic Disease) 01/2015 - 01/2011
2	Hyperlipidemias (Hyperlipidemia) 12/2010 - 03/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2005 - 09/2003
2	Ascites 07/2004 - 02/2002
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2022
1	Peritonitis 01/2019
1	Cytokine Release Syndrome 11/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Hypertrophy 01/2018
1	Acute-On-Chronic Liver Failure 01/2017
1	Bacterial Infections (Bacterial Infection) 10/2016
1	Alcoholism (Alcohol Abuse) 10/2016
1	Alcoholic Hepatitis 10/2016
1	Weight Loss (Weight Reduction) 02/2014

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 07/2022 - 10/2005
7	AutacoidsIBA 07/2022 - 06/2009
7	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 07/2011 - 09/2003
6	Proteins (Proteins, Gene)FDA Link 11/2018 - 02/2002
4	resolvin D1IBA 07/2022 - 11/2011
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2021 - 02/2002
4	AlbuminsIBA 01/2021 - 11/2018
4	CytokinesIBA 10/2020 - 10/2016
4	Interleukin-6 (Interleukin 6)IBA 11/2018 - 12/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 11/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 03/2010
3	Messenger RNA (mRNA)IBA 11/2018 - 02/2014
3	InterleukinsIBA 01/2017 - 03/2010
3	Insulin (Novolin)FDA Link 01/2015 - 12/2010
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2013 - 06/2009
3	AdipokinesIBA 12/2013 - 04/2010
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2005 - 01/2003
2	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 07/2022 - 12/2017
2	Human Serum Albumin FDA LinkGeneric 01/2021 - 10/2020
2	Docosahexaenoic AcidsIBA 01/2019 - 11/2011
2	ChemokinesIBA 01/2019 - 01/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2017 - 08/2016
2	Dinoprostone (PGE2)FDA Link 01/2016 - 02/2002
2	Glucose (Dextrose)FDA LinkGeneric 11/2013 - 06/2009
2	Nonesterified Fatty Acids (NEFA)IBA 01/2012 - 04/2010
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 07/2011 - 12/2010
2	ApolipoproteinsIBA 12/2010 - 03/2010
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2010 - 03/2010
2	Alanine Transaminase (SGPT)IBA 12/2010 - 03/2010
2	Apolipoproteins E (ApoE)IBA 12/2010 - 03/2010
2	Caspase 3 (Caspase-3)IBA 03/2010 - 07/2004
2	PPAR gammaIBA 06/2009 - 07/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2007 - 07/2005
2	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 12/2007 - 07/2005
1	CarbohydratesIBA 07/2022
1	Amino Acids FDA Link 07/2022
1	neonatal Fc receptorIBA 01/2021
1	GuanineIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Bacterial DNAIBA 10/2020
1	CytosineIBA 10/2020
1	Phosphates (Orthophosphate)IBA 10/2020
1	ZymosanIBA 01/2019
1	CreatinineIBA 01/2019
1	OsteopontinIBA 01/2019
1	ArginaseIBA 01/2019
1	dehydroacetic acid (DHAS)IBA 01/2019
1	17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA 01/2019
1	Leukotriene B4IBA 01/2019
1	InflammasomesIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 11/2018
1	nonmercaptalbuminIBA 11/2018
1	Soluble Guanylyl CyclaseIBA 01/2018
1	CollagenIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	oil red OIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	praliciguatIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	NucleotidesIBA 01/2017
1	4- (4- (3- (4- trifluoromethoxy- phenyl)ureido)cyclohexyloxy)benzoic acidIBA 01/2015
1	19,20-epoxydocosapentaenoic acidIBA 01/2015
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2015
1	Epoxy Compounds (Epoxides)IBA 01/2015
1	Epoxide HydrolasesIBA 01/2015
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2015
1	17,18-epoxy-5,8,11,14-eicosatetraenoic acidIBA 01/2015
1	LeptinIBA 02/2014
1	ResistinIBA 02/2014
1	ThiazolidinedionesIBA 08/2011
1	LipoxygenasesIBA 07/2011
1	LeukotrienesIBA 07/2011

Therapy/Procedure

3	Therapeutics 12/2017 - 12/2007